Rajputana Biodiesel Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Guidance rank: #6 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Rajputana Biodiesel Ltd Q2 FY27 key numbers
- Revenue
- Other Income for the same period is ₹131.31 lakhs, totaling ₹3,444.89 lakhs in income.
As stated in Rajputana Biodiesel Ltd's Q2 FY27 results statement · published 15 Nov 2026. Reported figures, not investment advice.
Based on Rajputana Biodiesel Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
EBITDA (Q2 FY27): ₹132.11 lakhs (Standalone; from Page 8 Cashflow statement adjusted operating profit).
From Rajputana Biodiesel Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.
How did Rajputana Biodiesel's revenue grow in the September 2026 quarter?
What happened to Rajputana Biodiesel's margins in Q2 FY27?
See what Rajputana Biodiesel Ltd said on profitability & margins — free account, 30 seconds.
What capex is Rajputana Biodiesel planning?
See what Rajputana Biodiesel Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Rajputana Biodiesel raising money or cutting debt?
See what Rajputana Biodiesel Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Rajputana Biodiesel's order book?
See what Rajputana Biodiesel Ltd said on order book & pipeline — free account, 30 seconds.
More Q2 FY27 results in Chemicals & Petrochemicals
Continue your research
What Rajputana Biodiesel's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Rajputana Biodiesel Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Rajputana Biodiesel Ltd Q2 FY27 results?
EBITDA (Q2 FY27): ₹132.11 lakhs (Standalone; from Page 8 Cashflow statement adjusted operating profit).
What is Rajputana Biodiesel Ltd share price analysis?
Rajputana Biodiesel Ltd currently shows a neutral. The stock trades at a P/E of 16.0 with a market cap of ₹145 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Rajputana Biodiesel Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
